Genetics Intellectual Property Timo Minssen Opportunities and challenges for user-generated licensing models in gene-editing Read more: Opportunities and challenges for user-generated licensing models in gene-editing
Genetics Health Law Policy Intellectual Property Pharmaceuticals Timo Minssen Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle? Read more: Will the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle?